This brand name is authorized in United States. It is also authorized in Australia, Brazil, Estonia, France, Germany, Hong Kong SAR China, Ireland, Italy, Japan, Malta, Netherlands, Poland, South Africa, Spain, Turkey.
The drug PARLODEL contains one active pharmaceutical ingredient (API):
1
|
UNII
FFP983J3OD - BROMOCRIPTINE MESYLATE
|
|
Bromocriptine is an inhibitor of prolactin secretion and a stimulator of dopamine receptors. The areas of application of bromocriptine are divided into endocrinological and neurological indications. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| PARLODEL Capsule | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G02CB01 | Bromocriptine | G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CB Prolactine inhibitors |
| N04BC01 | Bromocriptine | N Nervous system → N04 Anti-parkinson drugs → N04B Dopaminergic agents → N04BC Dopamine agonists |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 1443Y, 1444B |
| BR | Câmara de Regulação do Mercado de Medicamentos | 526512503112319, 526512504119317 |
| DE | Bundesinstitut für Arzneimittel und Medizinprodukte | 11030323, 11030346 |
| EE | Ravimiamet | 1464993 |
| ES | Centro de información online de medicamentos de la AEMPS | 54633, 56200 |
| FR | Base de données publique des médicaments | 63369053, 64141483, 66729097 |
| HK | Department of Health Drug Office | 01595 |
| IE | Health Products Regulatory Authority | 69175 |
| IT | Agenzia del Farmaco | 023781014 |
| JP | 医薬品医療機器総合機構 | 1169005F1200 |
| MT | Medicines Authority | AA1279/00101 |
| NL | Z-Index G-Standaard, PRK | 3239 |
| PL | Rejestru Produktów Leczniczych | 100051684, 100259462, 100288660, 100328884, 100394183, 100407804, 100426196 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8698856010032, 8698856170040, 8698856170057 |
| US | FDA, National Drug Code | 30698-201, 30698-202 |
| ZA | Health Products Regulatory Authority | Q/21.12/76 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.